U.K. PSE Rx only?
This article was originally published in The Tan Sheet
Executive Summary
The Proprietary Association of Great Britain says the U.K. Medicine and Healthcare products Regulatory Agency should not make pseudoephedrine prescription-only in an April 25 release. In March MHRA proposed Rx-only status for PSE- and ephedrine-containing OTCs to prevent the manufacture of methamphetamine (1"The Tan Sheet" March 12, 2007, p. 4). "We urge the government not to take disproportionate measures to control pseudoephedrine that would affect legitimate usage and consumer needs," PAGB says. The group encourages PSE restrictions similar to U.S. measures such as sales limits and behind-the-counter or locked cabinet storage (2"The Tan Sheet" March 6, 2006, p. 5)...